Efficacy and Tolerability of a Novel Topical Treatment Containing Pea Protein and Xyloglucan in the Management of Atopic Dermatitis in Children: A Prospective, Multicenter Clinical Study

INTRODUCTION: Atopic dermatitis (AD) is a chronic disease that occurs mainly in children. Topical corticosteroids are the main treatment for mild to moderate AD, although they can induce side effects. The efficacy and tolerability of xyloglucan and pea protein (XG-PP) was compared with hydrocortison...

Descripción completa

Detalles Bibliográficos
Autores principales: Sowlati, Mehdi, Morariu, Silviu-Horia, Orzan, Olguta, Veraldi, Stefano, Dodiuk-Gad, Roni P., Orasan, Remus I., Gainaru, Cristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613178/
https://www.ncbi.nlm.nih.gov/pubmed/37740857
http://dx.doi.org/10.1007/s13555-023-01035-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613178/
https://www.ncbi.nlm.nih.gov/pubmed/37740857
http://dx.doi.org/10.1007/s13555-023-01035-6

Ejemplares similares